Le rôle de l'axe intestin-cerveau dans le contrôle du cerveau humain et ses manifestations

30 sources13 sectionsHuman score 66

Communication bidirectionnelle de l'axe intestin-cerveau

L'axe intestin-cerveau, c'est un réseau de communication bidirectionnel qui relie le tube digestif au système nerveux central . Cette interaction repose sur une tas de médiateurs biochimiques et cellulaires. Ils intègrent les signaux de notre environnement et notre état physiologique interne . Le cerveau, par exemple, module l'activité intestinale, influençant même le microbiote. Inversement, les infos venant du système digestif, elles, affectent nos fonctions cérébrales et notre comportement . Quatre mécanismes majeurs permettent ces échanges : les voies hormonales, la médiation par le microbiote, la régulation immunitaire et la signalisation directe .

Sur le plan anatomique et fonctionnel, la transmission nerveuse directe utilise plusieurs circuits. Le nerf vague constitue une voie majeure pour la transmission des signaux sensoriels afférents depuis l'intestin vers le système nerveux central . Ce réseau s'appuie aussi sur les fibres spinales afférentes et le système nerveux autonome . Localement, le système nerveux entérique prend le relais pour traiter les messages neuronaux dans le tube digestif . De plus, le système sensoriel intestinal fait appel à des cellules épithéliales chimiosensorielles et des fibres nerveuses sensorielles. Ça forme une interface neuroépithéliale qui envoie les signaux intéroceptifs directement au système nerveux central .

Au-delà des nerfs, la communication passe par la circulation sanguine, les composantes immunologiques et biochimiques . La voie sanguine distribue plein de molécules régulatrices. Leur action centrale est modulée par la barrière hémato-encéphalique et les organes circumventriculaires . Parmi ces signaux, on trouve des neurotransmetteurs, des hormones intestinales, des médiateurs immunitaires et des métabolites d'origine microbienne . Le microbiote intestinal joue un rôle actif en produisant des métabolites comme les acides gras à chaîne courte, les métabolites d'indoles et en transformant les acides biliaires primaires en secondaires . En réponse à ces diverses sollicitations, le système nerveux central ajuste l'activité de l'intestin en modulant le système nerveux autonome et l'axe hypothalamo-hypophyso-surrénalien, qui gère les hormones corticosurrénaliennes .

Systèmes de signalisation neuronale et nerveuse

The gut and the brain chat through a complex anatomical and functional setup, with signals zipping back and forth via internal and external nervous systems. At the heart of this communication hub is the gut's sensory system, a tight partnership between chemosensitive epithelial cells and sensory nerve fibers . This neuroepithelial junction spots local cues and sends internal signals straight to the central nervous system . Then there are the extrinsic neurons outside the gut—both sensory and autonomic—which are major highways for these two-way signals, connecting your digestive world to your brain .

Within these external pathways, the autonomic nervous system has two branches, each with its own job. On one hand, parasympathetic neurons, mostly originating in the brainstem, reach the gut via the vagus nerve . They actively manage gut physiology, using acetylcholine as their main chemical messenger . The vagus nerve is thus a key route for sensory information coming up from the gut . This incoming vagal traffic itself gets tweaked by the enteric nervous system and even the gut's microbiome .

On the other hand, the sympathetic division of the autonomic nervous system kicks in to handle the body's stress response . Sympathetic neurons, starting in the spinal cord, send their tendrils to the digestive system. They use catecholamines to dial down normal gut functions like movement and secretion . Working together, the parasympathetic vagal pathways and the sympathetic signals from the spinal cord, the central nervous system tightly controls gut activity based on your overall physical state .

In close coordination with these external players, the enteric nervous system handles local information processing . Nestled right in the gut walls, enteric neurons are arranged into two main networks: the myenteric plexus and the submucosal plexus . This internal setup lets enteric neurons create self-contained reflex circuits that coordinate local tissue responses . At the same time, these networks constantly integrate signals from external neurons, bridging local internal sensations with commands from higher brain centers .

Rôle des métabolites microbiens

Gut microbes churn out metabolites, key players in the gut-brain chat . Short-chain fatty acids (SCFAs) really stand out among these active chemicals . They're crucial for controlling neuroinflammation and keeping brain cells healthy . SCFAs also tweak neurotransmission, maintain gut lining integrity, and manage nerve and immune system talk .

But it's not just SCFAs. Other bacterial byproducts influence how gut and brain communicate . Bile acids and indoles, for instance, are signaling molecules that can change neurotransmission, affect the gut barrier, and shift neuroimmune responses . All these compounds work together in complex networks. They involve the enteric nervous system, immune pathways, hormone signaling, and nerve signals back to the brain, especially via the vagus nerve .

These chemical messengers also impact brain development and the onset of various neurological and psychiatric disorders . When this signaling goes wrong, and the gut microbiome is out of whack, it's linked to problems with anxiety, autism, and other psychiatric conditions . These metabolic and immune processes are also deeply involved in neurodegenerative diseases like Alzheimer's and Parkinson's. In these conditions, certain bacteria and neuroinflammatory pathways contribute to things like amyloid aggregation . The available research, however, doesn't get into the exact biochemical routes or specific amounts of these metabolites crossing biological barriers to hit particular brain targets .

Influence du microbiote intestinal sur le développement et la fonction neuronale

L'intestin, ce tube digestif, est truffé de neurones. D'un côté, on a ceux qui viennent de la moelle épinière et du tronc cérébral, les extrinsèques. De l'autre, ceux qui vivent sur place, le système nerveux entérique . Les neurones extrinsèques comprennent des cellules somatosensorielles et des systèmes nerveux sympathiques et parasympathiques. Ces derniers partent respectivement de la moelle épinière et du tronc cérébral pour faire passer les messages du cerveau à l'intestin . Et au milieu de tout ça, le microbiote intestinal a un rôle clé. Au sein de cette architecture, le microbiote intestinal exerce une action déterminante sur la régulation du développement du système nerveux entérique ainsi que sur les fonctions intestinales induites par les neurones . Les neurones dans la paroi de l'intestin travaillent main dans la main avec les cellules immunitaires. Ensemble, ils forment des unités neuro-immunes qui réagissent aux signaux des aliments et des microbes présents . Ces unités discutent entre elles, créant un axe neuro-immunitaire contrôlé par le microbiote. Ça aide à garder la barrière intestinale solide, à gérer l'immunité et à protéger l'organisme .

Mais le microbiote ne s'arrête pas là. Il agit aussi sur notre cerveau, le cerveau central, pour régler et moduler son fonctionnement . Les échanges entre les microbes de l'intestin et notre cerveau passent par plusieurs chemins : le système immunitaire, le système nerveux entérique, le nerf vague, et même les substances que les microbes produisent . Les microbes dans notre intestin fabriquent plein de molécules et de neurotransmetteurs. Ils synthétisent des acides gras à chaîne courte et transforment les acides biliaires primaires en acides biliaires secondaires . En réponse à ces signaux venant de l'intestin, le système nerveux central, lui, ajuste l'activité du système nerveux autonome et celle de l'axe hypothalamo-hypophyso-surrénalien. Cet axe, c'est lui qui gère les hormones de stress, comme les corticosurrénaliennes .

Au niveau des cellules, le microbiote influence le système nerveux en modulant la façon dont réagissent diverses cellules immunitaires et de soutien du cerveau. Je pense notamment aux cellules microgliales, aux astrocytes et aux mastocytes . La microglie, les astrocytes et les mastocytes sont les soldats immunitaires du cerveau, surtout lors de ce qu'on appelle les réactions neuro-inflammatoires . Quand des déclencheurs d'inflammation apparaissent, souvent liés à des maladies neurodégénératives, ils peuvent lancer des réactions en chaîne. Ça libère des substances qui aggravent la neurodégénérescence . Dans ce contexte, la façon dont les neurones, la microglie et les changements au niveau des synapses interagissent pourrait aussi impliquer le microbiote intestinal . Les informations actuelles ne détaillent pas complètement les mécanismes moléculaires derrière tous ces circuits, ni au niveau local ni au niveau central. Il faut donc mener plus d'études pour bien comprendre ces interactions .

Mécanismes de modulation de la neuroinflammation par le microbiote

Le microbiote intestinal, c'est un vrai moteur pour la neuroinflammation, et il agit par plein de mécanismes qui s'entremêlent. Une synthèse publiée dans *The Lancet Neurology* explique que ces voies incluent la façon dont le système immunitaire est régulé, la production de métabolites qui peuvent agir sur les neurones, le maintien de l'intégrité des barrières intestinale et hémato-encéphalique, la migration vers le cerveau de lymphocytes qui vivent dans l'intestin, la signalisation par les acides biliaires, et même l'activité endocrinienne . Toutes ces communications, c'est autant de portes par lesquelles les communautés microbiennes de l'intestin peuvent influencer l'inflammation dans le système nerveux central, et ce, même sans contact direct avec le cerveau.

Parmi tous ces mécanismes, l'immunorégulation est vraiment clé. Des recherches publiées dans *Nature* en juin 2025 ont mis en lumière le rôle des cellules T CD4 spécifiques du commensal intestinal, qu'on appelle cellules T comm. Elles déclenchent la neuroinflammation . Quand l'intestin s'enflamme, ces cellules T comm peuvent se faufiler dans le système nerveux central, peu importe leur spécificité antigénique initiale. Une fois dans le cerveau, elles peuvent être réactivées par des antigènes provenant de protéines de l'hôte, grâce à un phénomène de mimétisme moléculaire. Ça leur permet de produire beaucoup de GM-CSF, d'IFNγ et d'IL-17A, et de causer des dommages neurologiques .

Le processus d'activation de la microglie par ces lymphocytes qui s'infiltrent s'appuie sur un programme encéphalitogène qui dépend du récepteur IL-23R, mais avec une production de GM-CSF qui, elle, n'en dépend pas . Cette double signalisation permet aux cellules T comm de transformer la microglie, qui est une cellule résidente du système nerveux central, en une machine inflammatoire. L'inflammation intestinale semble donc être un événement déclencheur. En déréglant les cellules T comm, elle favorise leur migration et leur réactivation pathogène loin de là, dans le cerveau.

Ces observations expérimentales, faites sur des souris, établissent un lien mécanistique direct entre une perturbation de l'homéostasie intestinale et l'apparition d'une inflammation du système nerveux central. Cependant, les sources que j'ai consultées ne précisent pas jusqu'où ces mécanismes ont été validés chez l'humain. Elles n'indiquent pas non plus s'ils s'appliquent de la même manière à tous les troubles neurologiques qui ont une composante immunitaire. De même, la contribution relative de chacune des voies mentionnées — signalisation vagale, acides biliaires, métabolites, intégrité des barrières — n'est pas quantifiée dans les preuves disponibles. Ces limites nous poussent à considérer les modèles animaux comme des preuves de concept plutôt que comme des démonstrations cliniques définitives.

Dysbiose intestinale et ses conséquences sur la barrière hémato-encéphalique

The gut-brain-microbiota axis chats through a few main channels: neural, endocrine, and immune . While the neural route, involving the vagus nerve, is a well-known part of this signaling, research is also pointing to a humoral pathway . This pathway uses the bloodstream and lymphatics. Countless molecular signals from gut microbes can move from the local gut lining right into general circulation . These microbial molecules might then cross the blood-brain barrier, landing smack in brain structures .

Keeping the blood-brain barrier intact is crucial for shielding the central nervous system from harmful stuff floating around the body . Mammalian brains are pretty special immunologically. They're cut off from the bloodstream by both the blood-brain barrier and the blood-cerebrospinal fluid barrier. Plus, they're wrapped in meninges and bathed in cerebrospinal fluid, with the leptomeninges keeping things separate . Because of how its anatomy, histology, and immunology govern its permeability, the blood-brain barrier is seen as a biomarker linked to neural disease . When its tightness changes, it's a critical factor in the development of brain damage that starts peripherally .

When the gut's microbial balance goes haywire (dysbiosis), it can mess with how permeable the blood-brain barrier is. We've seen this in mouse and rat models . This often ties into chronic, body-wide inflammation kicked off by the gut microbes . That systemic inflammation is mostly just too much gut inflammation, stemming from a messed-up mucosal immune system in the gut. Diet and age often play a role in this . It’s generated right where the gut barrier is, or it gets worse if that barrier breaks down .

A leaky or hyperpermeable gut barrier, thanks to the microbiota and its byproducts, lets chronic diseases start and spread along inflammatory pathways . Inflammatory cytokines mess with the signals that keep the blood-brain barrier strong, ultimately compromising its integrity . When dysbiosis and systemic inflammation make the blood-brain barrier more permeable, it lets risk factors slip through. This leads to big problems like neuroinflammation and neurodegeneration, and it even contributes to brain aging . Sources suggest the gut-brain-microbiota axis doesn't just affect brain function and psychiatric symptoms; it also helps trigger neurodegenerative diseases like Alzheimer's, Parkinson's, and multiple sclerosis .

Association entre le microbiote intestinal et les maladies neurodégénératives

The two-way conversations woven into the gut-brain axis concept are increasingly central to studying neurological diseases . This complex communication network links the central nervous system, the enteric nervous system, and the brain's emotional and cognitive centers. It operates through neural, immune, endocrine, and humoral pathways . Within this system, the interface connecting the gut microbiome, host immunity, and the nervous system appears to be a deciding factor in the pathogenesis of several illnesses . Specifically, disruptions originating in the gut are now seen as a potential missing piece in understanding the development, progression, and management of neurodegenerative conditions .

An imbalance in gut flora, called dysbiosis, where harmful bacterial species proliferate, is regularly noted in chronic illnesses, and particularly in neurodegenerative diseases . This imbalance is accompanied by inflammatory reactions that show up at the heart of various pathologies . The gut-brain axis thus plays a significant, documented role in major neurodegenerative disorders like Alzheimer's, Parkinson's, multiple sclerosis, and amyotrophic lateral sclerosis . This axis is also tied to other neuropsychiatric and neurological conditions, including depression and schizophrenia . Research data shows Alzheimer's has been the subject of the most extensive work, followed by Parkinson's, while findings for multiple sclerosis, though encouraging, remain more limited .

Targeted modulation of gut microbiome composition and activity holds notable therapeutic interest for slowing the progression of these conditions or easing their clinical symptoms . Administering probiotics in various forms — like bacterial strain blends, fecal microbiota transplantation, or diets rich in fermented foods — alongside prebiotics, synbiotics, or postbiotics (metabolites from prebiotics), shows beneficial potential against the pathogenic mechanisms of Alzheimer's, Parkinson's, multiple sclerosis, and amyotrophic lateral sclerosis . In humans, probiotic-based interventions yield favorable effects on mental health, cognition, and patient quality of life, while also impacting oxidative stress, immunological markers, and certain general metabolic parameters . The observed effectiveness, however, hinges on the neurodegenerative disease's clinical stage and pre-existing conventional treatments .

Despite these promising prospects, current research faces significant methodological limitations . A large proportion of the data comes from preclinical models or human studies on small cohorts in developed regions, preventing these results from being considered generally applicable or fully reliable at this point . Furthermore, investigations have primarily focused on bacteria using 16S rRNA sequencing due to its ease and low cost. This approach overlooks other integral components of the human microbiome, such as viruses, phages, and fungi, while also limiting the ability to characterize functional alterations . At this stage, direct causal relationships in humans can't be formally established. This necessitates longitudinal studies on larger cohorts, incorporating neuropsychiatric, metabolic, biochemical, and neuroimaging follow-ups to refine intervention protocols .

Impact de la dysbiose intestinale sur la dépression

Changes in gut microbiota composition and function, termed dysbiosis, are strongly linked to the onset and progression of depression by regulating the gut-brain axis . The gut microbiota and its metabolites are directly involved in this condition's pathology, offering a novel therapeutic target . Neurobiologically, depression-associated dysbiosis shows up as depleted metabolites, altered neural networks, reduced neuronal growth, less neural plasticity, and brain inflammation .

The microbial makeup of individuals with depression has distinct taxonomic signatures. Generally, depression means more pro-inflammatory bacteria and fewer butyrate-producing genera with anti-inflammatory properties . Depressed patients have a higher Firmicutes/Bacteroidetes ratio, an increase in the *Bacteroides* genus, and a decrease in *Blautia*, *Faecalibacterium*, and *Coprococcus* . What's more, *Eggerthella* levels are consistently higher, and *Sutterella* levels consistently lower, in people suffering from depression . Data also show steady drops in *Butyricicoccus*, *Coprococcus*, *Faecalibacterium*, *Fusicatenibacter*, and *Romboutsia*, alongside steady increases in *Eggerthella*, *Enterococcus*, *Flavonifractor*, *Holdemania*, and *Streptococcus* .

Mechanisms connecting microbial imbalance to mood disorders involve a breakdown in the digestive barrier's integrity. Increased gut permeability allows intestinal metabolites, bacterial particles, or microbes to travel through the damaged gut into the system . This abnormal passage intensifies systemic inflammatory responses, notably through a disruption of the Th17/Treg balance and higher levels of pro-inflammatory cytokines like interleukin-6, IL-1, and tumor necrosis factor-alpha . All these inflammatory and immune dysregulations actively contribute to the causes of depression by fueling neuroinflammation and synaptic dysfunction .

Influence de l'alimentation sur le microbiote intestinal et la santé cérébrale

What you eat is one of the biggest external forces shaping your gut microbes and their metabolism, throughout your life . The signals zipping around the gut-brain axis get a direct nudge from the nutrients you swallow, essentially building a food-microbiota-gut-brain loop . While balanced eating habits keep your thinking sharp and your mood steady, nutritional slip-ups seriously fuel the rise in brain disorders, including stress-related neuropsychiatric conditions and cognitive decline . Plus, your digestive tract is a key supplier of building blocks for your nervous system, like amino acids and neurotransmitters . When an imbalanced gut flora, thanks to a poor diet, gets thrown off, it can spark inflammation that might just pave the way for anxiety and depression .

Forget balanced diets; eating patterns packed with calories, fats, or sugars are linked to a worse mental state . The typical Western diet, along with highly processed foods low in plant fiber or polyphenols, messes with microbial diversity and lets opportunistic pathogens thrive . These diets ramp up the risk for brain and psychological issues, including mild cognitive impairment, dementia, and depression . On the neurological front, exposure to Western diet components triggers neurochemical changes in specific brain regions. Think hippocampus dysfunction, memory problems, and a breakdown in controlling your appetite . Eating this way long-term also encourages addictive eating behaviors and throws the hypothalamic-pituitary-adrenal axis out of whack, keeping you stuck in chronic stress, anxiety, and depression .

The nitty-gritty of how bad eating habits mess with your brain mostly involves inflammatory and metabolic pathways. High-fat diets crank up the release of pro-inflammatory cytokines, igniting neuroinflammation that’s directly tied to depressive symptoms, anxiety, and cognitive fumbles . Similarly, chowing down on ultra-processed foods, especially those in the NOVA 4 category, correlates with a spike in mental health symptoms and depressive episodes . These foods promote a low-grade inflammation that impacts your gut microbes . This whole process can deplete bacteria that produce pyruvate, messing with the absorption of key amino acids your brain needs to stay balanced .

Conversely, protective eating patterns offer tangible benefits for brain function by fine-tuning your gut ecosystem. The Mediterranean diet, plus plenty of fiber and fermented foods, shows positive effects on mental health . These perks come partly from supplying specific nutrients and producing beneficial microbial metabolites, like short-chain fatty acids . Still, even though using broad nutritional strategies that target the gut is a promising way to prevent or treat common mental health issues, more clinical research on human groups is needed. We need to better grasp individual differences and nail down evidence-based recommendations .

Interventions thérapeutiques ciblant l'axe intestin-cerveau

Knowing that the gut and the brain talk back and forth has opened doors for treatments that use gut microbes to help with brain and psychiatric problems . Among these, probiotics, prebiotics, and postbiotics are getting more attention. They can tweak the gut-brain axis and support the central nervous system . Doctors are looking at these therapies to help manage depression, anxiety, autism, schizophrenia, and even Alzheimer's disease .

How do they work? Probiotics protect the gut lining, aid digestion, and strengthen both the gut barrier and the blood-brain barrier . They also help make brain-derived neurotrophic factors (BDNF), which are crucial for neurons to grow and survive . Specifically, bacteria from the *Lactobacillus* and *Bifidobacterium* families are known powerhouses, actively keeping this gut-brain conversation healthy . So, giving probiotics might be a smart add-on treatment for metabolic and psychiatric conditions .

For neurodegenerative diseases like Alzheimer's, Parkinson's, multiple sclerosis, and ALS, nutrition changes and gut microbe adjustments are showing promising results . Giving probiotics in various forms—like bacterial blends, fecal transplants, or fermented foods—has positively impacted mental health, cognition, and overall quality of life for patients . What's more, prebiotic and postbiotic therapies have been particularly encouraging for certain neurodegenerative conditions. They target the root causes of the illness and fix disruptions in the microbial community .

It's not just probiotics and prebiotics; standard medications actually mess with your gut microbes too . Some antidepressants have built-in antimicrobial effects and change the gut bacteria in ways that seem to overlap with how they work, suggesting gut bacteria might help them do their job . For example, when antidepressants reduce the amount of *Ruminococcus flavefaciens*, it’s strongly linked to less depressive behavior . Conversely, directly giving *Ruminococcus flavefaciens* downregulates genes involved in neural plasticity and upregulates genes for mitochondrial oxidative phosphorylation in specific brain areas, like the medial prefrontal cortex .

Given all this biological complexity, combined approaches are increasingly recommended. Think psychotropic drugs, psychobiotics, and a balanced diet all working together to get the best clinical outcomes . The right diet helps produce the neurotrophic factors and neuropeptides that keep the gut-brain axis humming . But, how well these interventions work really depends on a lot of things. The specific bacterial strain, the dose, how long you take it, your age, your body's makeup, how far along the neurodegenerative disease is, and what other meds you're on all play a role . Right now, we definitely need more solid human trials to nail down these targeted treatment plans .

Défis et incohérences dans la recherche sur l'axe intestin-cerveau

Exploring the gut-brain axis interactions is tricky business, riddled with big disagreements and major methodological headaches . While observational studies have shown lots of links between gut microbe data from sequencing and human mental traits, these connections often don't line up from one study to the next . This inconsistency makes it tough to prove how these links actually work and really hard to pin down direct cause-and-effect relationships between microbe makeup and psychological or cognitive states . Plus, we're still missing a lot of understanding about how things cause other things, making it difficult for researchers to formally connect changes in microbes to what happens in our nervous systems .

A big reason for this lack of consistent results? Recurring methodological limits in the studies we already have. Non-standardized protocols, tiny sample groups, and confounding factors like environmental and dietary shifts all mess with how much we can trust the conclusions . In human clinical studies, small participant numbers and short observation times also hurt the ability to make solid comparisons between different research projects . What's more, individual host characteristics—like age, sex, BMI, medication use, and overall lifestyle—act as powerful confusers that skew microbe analyses and limit valid deductions . Without clear guidelines on how to isolate and control these factors in complex microbial relationships, the discrepancies in findings only get worse .

On top of these pitfalls, there's a huge hurdle in translating findings. Most of the evidence linking the gut microbiome to brain function comes from animal models, not from carefully controlled human clinical trials . Human studies are held back by a lack of specific biomarkers for both diseases and the microbiome, a shortage of clinically relevant behavioral phenotypes, and inadequate tools for properly categorizing patient cohorts . The sheer complexity of the gut ecosystem itself is also a technical barrier, making it seem impossible to fully decode the microbe-host relationship with just one analytical method .

To get past these scientific dead ends and fill in the gaps, research needs a standardized methodological framework for human studies . This means solid guidelines for gut-brain axis specifics, thorough analysis of biological samples, and identifying rigorously validated biomarkers . Developing advanced new models for in vitro and in vivo investigations into the underlying mechanisms is just as crucial . Finally, we really need to lean more on omics technology combined with the right bioinformatics support to reliably translate and interpret discoveries from these biological systems .

Implications cliniques et besoins de recherche future

The gut-brain axis holds major medical potential, but we're still figuring out how to use it effectively. Gut problems, it turns out, can actually raise your risk for neurological issues . This constant back-and-forth communication is deeply involved in a range of neuro-immune and psychiatric conditions, affecting everyone from kids to adults . Even changes in gut bacteria can stir up neuroinflammation, influence how a disease progresses, and affect how well treatments work . We see gut flora shifts in diseases like multiple sclerosis, autoimmune brain inflammation, and epilepsy .

In neurodegenerative diseases—think MS, Alzheimer's, Parkinson's, or ALS—we've documented intestinal dysbiosis. Fixing it might just help with symptoms and slow down the disease's march . Strategies to tweak the microbiota include giving patients probiotics, whether as bacterial mixes, fecal transplants, or in fermented foods. Prebiotics, synbiotics, and postbiotics from prebiotic metabolites are also on the table . In people, these approaches have shown benefits for specific symptoms, metabolic and immune markers, oxidative stress, mental well-being, cognition, and overall quality of life . Prebiotic and postbiotic methods, in particular, have shown promising results for certain neurodegenerative conditions .

Yet, these strategies aren't standard practice yet. Currently, only the ketogenic diet gets common doctor recommendations; other gut-focused treatments are still in the research phase . Still, changing your diet, using prebiotics, probiotics, postbiotics, and fecal transplants offer possibilities for future therapies that can modify disease course . How well probiotic treatments work depends heavily on how advanced the patient's neurodegenerative disease is and what standard treatments they're already getting .

All this points to what we really need to focus on in future studies. While better analytical tools are improving our chances of applying this to patients, big hurdles remain. Part of the problem is that most current studies are just correlational. Plus, figuring out and interpreting microbiota data is inherently complicated . Human data is also pretty scarce compared to what we have from animal models . To really nail down therapeutic plans for neurodegenerative diseases, we need more research . This research absolutely must include larger groups of people and track them long-term, assessing everything from neuropsychiatric and metabolic health to biochemical markers and brain imaging .

Open questions

— Comment les différentes voies de communication de l'axe intestin-cerveau interagissent-elles pour réguler la fonction cérébrale ?
— Quels sont les biomarqueurs spécifiques du microbiote et de la maladie permettant une meilleure stratification des cohortes dans les études cliniques ?
— Comment optimiser les protocoles thérapeutiques pour les maladies neurodégénératives en tenant compte de l'état de la maladie et des médicaments existants du patient ?

Sources

Includes results from PubMed® (NCBI, U.S. National Library of Medicine). NCBI disclaimer